These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 37478222)
1. Development of a prognostic signature based on anoikis-related genes in hepatocellular carcinoma with the utilization of LASSO-cox method. Yu Z; Shi FE; Mao Y; Song A; He L; Gao M; Wei H; Xiao F; Wei H Medicine (Baltimore); 2023 Jul; 102(29):e34367. PubMed ID: 37478222 [TBL] [Abstract][Full Text] [Related]
2. Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma. Pang M; Sun X; He T; Liang H; Yang H; Chen J Aging (Albany NY); 2023 Oct; 15(19):10253-10271. PubMed ID: 37787988 [TBL] [Abstract][Full Text] [Related]
3. Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma. Zhu J; Zhao W; Yang J; Liu C; Wang Y; Zhao H Anticancer Drugs; 2024 Jun; 35(5):466-480. PubMed ID: 38507233 [TBL] [Abstract][Full Text] [Related]
4. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
5. Develop a Novel Signature to Predict the Survival and Affect the Immune Microenvironment of Osteosarcoma Patients: Anoikis-Related Genes. Yang M; Su Y; Xu K; Zheng H; Cai Y; Wen P; Yang Z; Liu L; Xu P J Immunol Res; 2024; 2024():6595252. PubMed ID: 39431237 [TBL] [Abstract][Full Text] [Related]
6. Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma. Xiong C; Pan G; Wang H; Meng G; Yan L; Li R; Yan Y; Yang Y; Zhang X; Yang C; Dong Z; Li T J Cancer Res Clin Oncol; 2023 Dec; 149(18):16869-16884. PubMed ID: 37736789 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust epithelial-mesenchymal transition (EMT)-related prognostic signature for hepatocellular carcinoma. Chen S; Zhao E Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101587. PubMed ID: 33662631 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a robust immune-related risk signature for hepatocellular carcinoma. Liu Z; Jiao D; Liu L; Zhou X; Yao Y; Li Z; Li J; Chen J; Lei Q; Han X Medicine (Baltimore); 2021 Mar; 100(10):e24683. PubMed ID: 33725827 [TBL] [Abstract][Full Text] [Related]
9. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
10. Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings. Zhu S; Zhao Q; Fan Y; Tang C BMC Urol; 2023 Dec; 23(1):199. PubMed ID: 38049825 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of multi-omic prognostic signature of anoikis-related genes in liver hepatocellular carcinoma. Ding D; Wang D; Qin Y Medicine (Baltimore); 2023 Nov; 102(46):e36190. PubMed ID: 37986299 [TBL] [Abstract][Full Text] [Related]
12. Identifying the predictive role and the related drugs of oxidative stress genes in the hepatocellular carcinoma. Nie G; Zhu X; Zhang H; Wang H; Yan J; Li X Cancer Rep (Hoboken); 2024 Apr; 7(4):e1978. PubMed ID: 38599581 [TBL] [Abstract][Full Text] [Related]
13. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis. Yan Z; He M; He L; Wei L; Zhang Y Front Immunol; 2021; 12():723271. PubMed ID: 34925311 [TBL] [Abstract][Full Text] [Related]
15. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma. Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X Front Immunol; 2023; 14():1218661. PubMed ID: 37662906 [TBL] [Abstract][Full Text] [Related]
16. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma. Gao S; Zhang L; Wang H Funct Integr Genomics; 2023 Aug; 23(3):262. PubMed ID: 37540264 [TBL] [Abstract][Full Text] [Related]
17. Mining prognostic markers of Asian hepatocellular carcinoma patients based on the apoptosis-related genes. Yan J; Cao J; Chen Z BMC Cancer; 2021 Feb; 21(1):175. PubMed ID: 33602168 [TBL] [Abstract][Full Text] [Related]
18. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma. Chen QF; Li W; Wu PH; Shen LJ; Huang ZL World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872 [TBL] [Abstract][Full Text] [Related]
19. [Construction of a prognostic model for hepatocellular carcinoma based on pyroptosis-related genes]. Rong HC; Zhao WF; Zheng N; Guo ZH; Wang YW; Huang XP Zhonghua Gan Zang Bing Za Zhi; 2023 May; 31(5):509-517. PubMed ID: 37365028 [No Abstract] [Full Text] [Related]
20. Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma. Chen C; Liu YQ; Qiu SX; Li Y; Yu NJ; Liu K; Zhong LM BMC Cancer; 2021 Jun; 21(1):693. PubMed ID: 34116652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]